Disclosures for "Correlation Between Visual Network Integrity and Visual Function in Multiple Sclerosis Patients"
-
Dr. Dias Veloso has nothing to disclose.
-
Mr. Dos Santos Silva has nothing to disclose.
-
Dr. Carvalho has nothing to disclose.
-
Sarita Walvekar has nothing to disclose.
-
Dr. Azambuja has nothing to disclose.
-
Dr. Pereira has nothing to disclose.
-
Dr. Passos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Passos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Passos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Passos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMS. Dr. Passos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Passos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Passos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
-
Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. The institution of Dr. Sato has received research support from Biogen. The institution of Dr. Sato has received research support from Merck.
-
Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ASTRAZENECA. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ASTRAZENRCA. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMS.